FDA Approves First Medication for Obstructive Sleep Apnea
5 days ago · Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in...
FDA approves weight loss drug Zepbound for sleep apnea - NBC News
5 days ago · The approval is based on two trials of men and women with obesity and moderate to severe sleep apnea. In Lilly's sleep apnea research, people who took Zepbound lost around 20% of their body weight ...
FDA Approves Zepbound for Obstructive Sleep Apnea - WebMD
3 days ago · Results showed that Zepbound significantly reduced breathing interruptions (apnea and hypopnea) during sleep compared to the placebo. More patients treated with Zepbound saw their symptoms...
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
3 days ago · MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the...
FDA approves Zepbound® (tirzepatide) as the first and only ...
5 days ago · About Zepbound ® (tirzepatide) injection Zepbound ® (tirzepatide) injection is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity. It is also approved in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults ...
FDA approves weight-loss drug Zepbound for obstructive sleep ...
5 days ago · The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...
GLP-1 Zepbound is approved as first drug for sleep apnea
3 days ago · The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.